Investment research. Portfolio intelligence.

Continuous financial intelligence, built around you.

Understand the businesses you invest in. Bring your holdings together. Get weekday briefs on the companies you own and follow.

Browse all research Connect your portfolio

10 days of Pro, or of Firm on a work email address to start. No card needed.

For your firm’s clients, funds and portfolios

Your intelligence, connectedCompany research → your portfolio

Understand. Connect. Stay informed.

Discover a company

Bring your holdings

Follow what changes

Explore the published coverage

Start with the evidence. Make it relevant to you.

Follow companies or bring in your portfolio. Weekday briefs connect updates to your holdings and the companies you follow.

Explore the company intelligence Inspect the method

Research with its sources and working shown

Weekday briefs on holdings and followed companies

Your questions, files and firm's method

Start with something useful

Read the evidence behind a business.

Published business-model and financial analysis is free to read. The full report and Mool’s research view open with Individual or above.

485 companies across 11 sectors in published coverage.

An excerpt from Mool’s published research

Mankind Pharma Ltd.

NSE: MANKIND · Report 26 Oct 2026

Business model and financial foundation

Mankind Pharma (NSE: MANKIND), Pharmaceuticals - domestic branded formulations: revenue of ₹14,278 crore in FY26 (+17.0% on FY25), an EBITDA margin of 24.5%, net profit of ₹1,913 crore and net debt of ₹3,932 crore.

Read the analysis and its sources

Figures from this public analysis

Revenue, FY26 (₹ crore): 14,278; consolidated
Revenue growth, FY26: +17.0%; on FY25
EBITDA margin, FY26: 24.5%; EBITDA (company definition) / revenue

The figures retain the periods and comparisons stated in the analysis. This excerpt describes the business; full research access is explained above.

The latest company reports, newest first
Company	Sector	Report	Close, 23 Oct
Mankind Pharma Ltd.NSE: MANKIND	HealthcareDrug Manufacturers - Specialty & Generic	26 Oct 2026	₹2,212.60 last close on 23 Oct 2026−2.77%
Gravita India Ltd.NSE: GRAVITA	IndustrialsMetal Fabrication	26 Oct 2026	₹1,343.20 last close on 23 Oct 2026−1.36%
Dalmia Bharat Ltd.NSE: DALBHARAT	Basic MaterialsBuilding Materials	26 Oct 2026	₹1,591.30 last close on 23 Oct 2026−1.81%

Browse all company research

Mool's research is written by AI agents and published by Mool Capital Private Limited, a SEBI-registered Research Analyst, which is responsible for it. It is general research, not advice for any individual.

One platform. Built around your world.

For the money you own.
For the people you serve.

For individuals

Make sense of your investments.

Discover a company through its research. Bring your holdings together. Follow the changes and ask the questions that make the analysis useful to you.

Published company research and local market notes
Supported broker connections, statements and manual holdings
Proactive briefs and analysis on your own questions

Explore Mool for you

For firms

Bring intelligence to your clients.

Explore licensing Mool for a firm-branded client experience, or for your funds and portfolios. Build around your investment method and the relationships you already own.

Wealth managers and advisory firms
Asset managers, AMCs and institutional investors
Family offices and multi-asset investment teams

Explore Mool for your firm

A relationship with your investments

The first answer
is a starting point.

Your investments keep changing. Keep the evidence close, connect it to what you own and build on the questions you have already asked.

Your intelligence over time

Illustrative product journey

Discover

Start with a company you care about.

Read its published business model and financial foundation. Inspect the source periods and figures before deciding what to explore next.

The context you bring forward

Company, listing, source documents and dated analysis

Read the public analysis
Inspect the evidence
Follow the company in Mool

Your next question

“How does this business make money, and what could change?”

Explore published research

Local context. A wider perspective.

Follow your market.
Understand the world around it.

All market notes

Sourced news and upcoming events in the markets Mool’s brief follows. Market notes and published company coverage are different: the directory shows which companies have research today.

Depth when you need it

Ask the next question.
Put the intelligence to work.

Investigate a company, examine a portfolio, assess a deal or build a financial model. Explore the evidence, analysis and editable outputs behind each kind of work.

Explore research and portfolio workflow examples

Put Mool to workIllustrative briefs and output structures

Investors and investment teams

Understand what drives the business. Test what comes next.

Go from a stack of filings to a company view you can interrogate: the economics, financial history, assumptions and scenarios behind it.

An example brief

Research this company from its filings. Explain the segment economics, build driver-based forecasts, compare the closest peers and show what changes when the assumptions move.

What Mool works from

Company and question: A listed name, the market and the decision you are researching.
Your material: Annual reports, earnings transcripts, presentations or an existing model.
External evidence: Filings, web research and market data for listed companies worldwide.

The work behind the answer

01Read the source material in full
02Compute financials and peer comparisons
03Build scenarios and document assumptions

Explore the output

Example report outline

Company research

01
The business behind the numbers
Segment economics, competitive position, growth drivers and the financial foundation.
02
The model behind the view
Historical financials, driver-based forecasts and base, upside and downside scenarios.
03
The questions that matter
Assumptions, evidence gaps, risks and what would change the analysis.

Go from the report to the supporting analysis. Charts and sensitivity panels are available where the work calls for them.

Public Markets playbooks and editable Office files are available on Pro. Examples describe possible work; the brief and available evidence determine the actual output.

Try this workflow Explore this workflow

See all platform capabilities

Make the intelligence yours.

Connect your portfolio Explore the research